Resources

Even if diabetes is left out of the equation, higher-than-optimum blood glucose is a major worldwide killer, equivalent to smoking deaths, according to researchers.

If Fluoride in our drinking water prevents cavities then why not statins? Statins found to reduce heart attacks by 29% and strokes by 14% in those without heart disease.

Jury is still out on Exubera.

Medication nonadherence was significantly associated with increased risks for all-cause hospitalization and for all-cause mortality.

Within weeks of Januvia being approved, Merck & Co. is ready to come out with a combination product of Januvia and metformin.

Actos is a drug used by millions of diabetics to control their blood may be valuable in preventing a common overlooked liver problem as well.

Bentley Pharmaceuticals, Inc., announced that, following successful review of its Investigational New Drug (IND) application by the FDA, a phase II program is now in effect and under way evaluating Bentley’s human recombinant Intranasal Insulin Spray for the treatment of postprandial hyperglycemia in diabetics.

Naturlose has a beneficial effect on modulating postprandial blood glucose.

End of research on cholesterol medicine torcetrapib is a big blow for firm

Landmark Study compares effectiveness of single therapy with rosiglitazone, sulfonylurea and metformin in a head to head comparison with 4360 newly diagnosed Type 2’s.